US37611X2099
US37611X2099
Ginkgo Bioworks Holdings, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 170.155.000 | 227.043.000 | 25.1% |
| Cost of Revenue | 46.972.000 | 44.548.000 | 5.4% |
| Gross Profit | 123.183.000 | 182.495.000 | 32.5% |
| 427.063.000 | 670.222.000 | 36.3% | |
| Operating Income | -303.880.000 | -487.727.000 | 37.7% |
| Pretax Income | -313.600.000 | -547.508.000 | 42.7% |
| Net Income Common Stockholders | -312.763.000 | -547.029.000 | 42.8% |
| -- | -- | -- | |
| -- | -- | -- |